Researchers are excited about this new drug, a groundbreaking dual treatment showing remarkable data in early trials for size reduction . It functions by modulating several pathways : GLP-1 and GIP, these, when activated , assist control appetite and enhance energy expenditure . Preliminary reports indicate substantial size reduction and potenti… Read More